Ordered one; I hope this will serve me well and make it easier to share data with my endocrinologist. I don't always wear my CGM, and when I don't it's hard to let them know what my manual test results were.
Glucose meters are eligible for FSA reimbursement, so this is a good use of half of the remaining funds from 2016's FSA. I'll have to decide whether to pay for the test strips via FSA as well (that's also an eligible expense) or pay out of pocket, but either way, the cost for this is about the same as what I pay now for lancets and test strips through an ongoing prescription. If it doesn't work out, I can always use my current meter.
As for lancing devices, the cost for those is trivial. It's always been the case that the test strips are the profit center. And, unfortunately, every meter uses a different type of test strip so it's impossible to buy a generic strip that works with brand-name meters. It's disgusting. At least this meter has a flat-rate monthly price for whatever number of test strips you need, and the amount you get is the amount you actually need/use. I looked at my copay history and the comparison is favorable for me.
According to the FAQ, the lancing device uses generic lancets. That's something that'll cost less than the meter I've got now, as I'm not sure that generic lancets work with its lancing device. You can get a box of generic lancets (commonly 100 per box) for a few dollars at most major pharmacies, and not everyone replaces the lancet with each test so each box can last a long time. (Not advised, but people do it). Lancets do not require a prescription to purchase.
The no-prescription-required deal here is also good. I do maintain prescriptions for the medications I use and I do easily get prescription renewals from my clinic, but not having to have one is one less hassle to remember to handle.
I have a Verio meter now and I haven't been happy with its app or its sharing options. My copay is similar to yours, but the particular meter I am using right now doesn't work with generic lancets to the best of my knowledge. Keeping roughly the same monthly cost for the amount of test strips I need with better app support and better sharing is personally worth it for me.
I did once try to switch to a different brand of meter, but my insurer refused to cover it as it wasn't a OneTouch meter. That bothered me, as I think I should be free to use whatever meter I'd like to use as long as it meets FDA requirements as all such meters are required to do. Why is one meter okay but another is not?
I've also had this problem with some medications, and now I have to use one that is painful to administer instead of another that was painless because my insurer refused to cover the painless one and out of pocket it was hundreds of dollars. Both treat the same condition, are FDA approved for the same "label", and have the same effect/results. I never got a satisfactory explanation, either.
I like the Verio meter, but for the twice a day requirement, it works for me. I'm with you on the sharing part of it. I'm a bit of two minds on the "gotta use LifeTouch" thing. Part of me sees it your way, and the other part sees it the insurance company's way, where they're in the business to make money, and if Lifescan gives them strips for cheap, then they can spend less money. BTW, I HATED the blue ones, with too many "Error 5" (not enough blood on the strip...)
I do think that this methodology will break soon on the blood testing, but the CGM companies may be a mitigating factor.
OK, let me back the truck up a bit...
There are 3 forces at play here...
1. CGM companies making fingersticks a rarity. Dexcom working on the 2 week CGM, and the FDA allowing those on the Dexcom (may be others) G5 able to dose from them. This is a move away from doing fingertip BG testing, putting pressure on 2 and 3, below.
2. Companies like One Drop (odd name... how many drops are other diabetic companies requiring?) doing the subscription model, based on usage. (Privacy concerns notwithstanding - "we get to see everything that you do in the blood testing world..." Before CGMs, when I was high, I'd test every 30 minutes to be sure the insulin was working) This is a pressure on companies like Lifescan.
3. And lastly, the "stabilizing" force of the current contenders, led by Lifescan, where they sell to the insurance companies (and their fulfillment contractors, like Express Scripts) very cheap (in relation to going to the store... really? $150 for 100 test strips?), and that lets them use them as formulary drugs. This puts pressure on the other companies to come up with something revolutionary (Item #2 above).
I think this battle will continue on for another 10 years, and CGM companies are probably going to win this. For a lot of diabetics, the convenience of one puncture per 2 weeks (yeah, I know they fall off, but Dexcom is really good about replacing them) is a lot better than the 1 puncture in a nerve centric area (fingertips).
Now, to get the FAA to let me use my CGM when I fly, instead of requiring me to poke my fingers once an hour, while flying a Cessna.